Migraines occur when inflammation around the brain triggers trigeminal nociceptors-cells responsible for pain sensations around the face-to transmit chemical signals.
Here we show that charged sodium-channel blockers can be targeted into nociceptors by the application of TRPV1 agonists to produce a pain-specific local anaesthesia.